Angiolillo, Dominick J <br/><br/>
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial.  [electronic resource] 

 -  European heart journal  Apr 2011 
 - 838-46 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-9645 
<br/><br/><label>Standard No.: </label>10.1093/eurheartj/ehq494  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aspirin--therapeutic use<br/>Clopidogrel<br/>Coronary Artery Disease--complications<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Angiopathies--drug therapy<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Piperazines--administration & dosage<br/>Platelet Activation--drug effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Prasugrel Hydrochloride<br/>Prospective Studies<br/>Thiophenes--administration & dosage<br/>Ticlopidine--administration & dosage<br/>Treatment Outcome<br/>Young Adult